Pfizer Inc. on Thursday said second-quarter earnings from continuing operations rose more than 10 percent on higher sales of medicines like cholesterol fighter Lipitor and Celebrex for arthritis.
[News Source]
[News Source]
Blogosphere: TechnoratiFeedsterBloglines
Bookmark: Del.icio.usSpurlFurlSimpyBlinkDigg


